Histiocytic sarcoma with secondary involvement of the skin and expression of CD1a: evidence of indeterminate cell differentiation?

J Cutan Pathol. 2006 Jun;33(6):437-42. doi: 10.1111/j.0303-6987.2006.00453.x.

Abstract

Background: Histiocytic sarcoma is an exceedingly rare malignant neoplasm composed of cells with a monocyte/macrophage phenotype. In the current nosology of histiocytic neoplasms, histiocytic sarcoma is separate from indeterminate cell histiocytosis, a generally benign disorder characterized by proliferation of a CD1a+ and S-100+ population of cells lacking Birbeck granules usually limited to the skin.

Methods: We present a case of histiocytic sarcoma in a 64-year-old man presenting as a peritonsillar mass and secondarily involving the skin.

Results: The malignant cells in the extracutaneous foci of disease expressed macrophage-associated antigens including S-100 but were CD1a-. The malignant cells in the skin coexpressed CD1a and S-100 but lacked ultrastructural features of Langerhans cells, findings indicative of indeterminate cells.

Conclusions: We discuss the clinical and histopathologic differential diagnosis in association with prior reported cases of histiocytic sarcoma, particularly in cases involving the skin and cases expressing the Langerhans cell-associated antigen CD1a.

Publication types

  • Case Reports

MeSH terms

  • Antigens, CD1 / metabolism*
  • Antigens, Neoplasm / metabolism
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / metabolism
  • Bleomycin / administration & dosage
  • Cell Proliferation
  • Cell Transformation, Neoplastic*
  • Chemotherapy, Adjuvant
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Histiocytes / metabolism
  • Histiocytes / pathology*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prednisone / administration & dosage
  • Sarcoma / metabolism
  • Sarcoma / secondary*
  • Sarcoma / therapy
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / secondary*
  • Skin Neoplasms / therapy
  • Tonsillar Neoplasms / metabolism
  • Tonsillar Neoplasms / pathology*
  • Tonsillar Neoplasms / therapy
  • Vincristine / administration & dosage

Substances

  • Antigens, CD1
  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • CD1a antigen
  • Bleomycin
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • VACOP-B protocol